Remarkably, SUV420H2 was the top candidate among the 11 tumor suppressors, which was also related to breast cancer metastasis and has not been reported as a miR-29a target in cancer, and was thus selected for further experimental verification. This evidence concerns the gene KMT5C and breast carcinoma.